Curahist Dm
NDC Package 83335-105-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Curahist Dm is uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies:■ runny nose ■sneezing ■itching of the nose or throat■ itchy, watery eyes ■cough due to minor throat and bronchial irritation associated with a cold ■alleviates cough to help you sleep ■nonnarcotic cough suppressant for the relief of cough. Marketed by Wittman Pharma, Inc., this product is identified by NDC 83335-105 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
83335-105-16
Package Description
473 mL in 1 BOTTLE, PLASTIC
Product Code
83335-105
11-Digit Billing Format
83335010516
RxNorm Crosswalk
  • RxCUI: 1423307 - dextromethorphan HBr 7.5 MG / pyrilamine maleate 7.5 MG in 5 mL Oral Solution
  • RxCUI: 1423307 - dextromethorphan hydrobromide 1.5 MG/ML / pyrilamine maleate 1.5 MG/ML Oral Solution
  • RxCUI: 1423307 - dextromethorphan hydrobromide 7.5 MG / pyrilamine maleate 7.5 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Curahist Dm
Dosage Form
-
Usage Information
Uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies:■ runny nose ■sneezing ■itching of the nose or throat■ itchy, watery eyes ■cough due to minor throat and bronchial irritation associated with a cold ■alleviates cough to help you sleep ■nonnarcotic cough suppressant for the relief of cough

Regulatory & Marketing

Labeler Name
Wittman Pharma, Inc.
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-15-2024
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83335-105-16 identifies a specific commercial package of 473 ml in 1 bottle, plastic of Curahist Dm, labeled by Wittman Pharma, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wittman Pharma, Inc. on January 15, 2024. The current certification is valid through December 31, 2025.

How is this Wittman Pharma, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83335010516. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83335-105-16
11-Digit CMS (5-4-2)
83335-0105-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.